Other languages Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Market Closed - Nasdaq Stockholm Other stock markets 08:59:39 26/04/2024 pm IST			5-day change	1st Jan Change
17.3 ^SEK	+3.72%		+6.00%	+22.00%

04/04	Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	CI
19/03	Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	04/04
Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	19/03
Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02
Vicore Pharma Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Vicore Pharma Signs Licensing Deal for Idiopathic Pulmonary Fibrosis Drug Candidate	09/02
Alex Therapeutics and Vicore Pharma Announces Positive Results of the COMPANION Study	04/01
Vicore Pharma Holding AB Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates	02/01
Vicore Pharma Holding AB Appoints Bertil Lindmark as Chief Medical Officer	18/12
Vicore Pharma Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	02/11
Vicore Pharma Holding AB Announces the Nomination Committee for the 2024 Annual General Meeting	31/23/31
Vicore Pharma Holding AB Provides Update Regarding Phase 1 Study of C106	27/23/27
Vicore Pharma's New CEO to Formally Take Office	08/23/08
Vicore Pharma Holding AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/23/24
Vicore Pharma Holding AB Reports Data from EndoPAT® Exploratory Trial	22/23/22
Vicore Pharma Names New CEO to Start in September	13/23/13
Vicore Pharma Holding AB Announces Executive Changes	13/23/13
Vicore Pharma Initiates Recruitment Process as CEO Plans Retirement	05/23/05
EU Grants Patent to Vicore Pharma's Improved Pulmonary Fibrosis Drug Candidate	07/23/07
Vicore Pharma Holding AB Reports New 36-Week Data from the Air Trial Demonstrating Sustainable Disease Stimulating the Potential of A New Class of Drugs to Stop Disease Propose and Restate in IPF Patients	19/23/19
Vicore Pharma Holding AB Strengthens Its Board of Directors	12/23/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Other languages

Filters